India, Oct. 29 -- As India faces a significant burden of chronic respiratory conditions Philips, a global leader in health technology, launches Oxygenate 5 in India. Designed for people requiring long-term supplemental oxygen at home, the new stationary oxygen concentrator brings together dependable oxygen delivery with patient-centric features designed around the everyday experience of therapy.

As per reports, Chronic obstructive pulmonary disease (COPD) affects around 13% of adults in India, rising to 27% among those aged 60 and above, highlighting the significant burden of the disease. For patients with chronic respiratory conditions who develop severe hypoxaemia, long-term oxygen therapy can be an important part of ongoing care. Oxyg...